187 related articles for article (PubMed ID: 31874465)
1. Factors Associated with Knee Arthroplasty in a Knee Osteoarthritis Patient Cohort Treated with Intra-articular Injections of Hylan G-F 20.
Ong K; Lau E; Runa M; Daley W; Altman R
J Knee Surg; 2021 Jul; 34(8):886-897. PubMed ID: 31874465
[TBL] [Abstract][Full Text] [Related]
2. Severe Acute Localized Reactions Following Intra-Articular Hyaluronic Acid Injections in Knee Osteoarthritis.
Ong KL; Runa M; Xiao Z; Ngai W; Lau E; Altman RD
Cartilage; 2021 Dec; 13(1_suppl):1474S-1486S. PubMed ID: 32063023
[TBL] [Abstract][Full Text] [Related]
3. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.
Adams ME; Atkinson MH; Lussier AJ; Schulz JI; Siminovitch KA; Wade JP; Zummer M
Osteoarthritis Cartilage; 1995 Dec; 3(4):213-25. PubMed ID: 8689457
[TBL] [Abstract][Full Text] [Related]
4. Is Intra-Articular Injection of Synvisc Associated with a Delay to Knee Arthroplasty in Patients with Knee Osteoarthritis?
Ong KL; Runa M; Lau E; Altman R
Cartilage; 2019 Oct; 10(4):423-431. PubMed ID: 29779404
[TBL] [Abstract][Full Text] [Related]
5. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo controlled trial.
Chevalier X; Jerosch J; Goupille P; van Dijk N; Luyten FP; Scott DL; Bailleul F; Pavelka K
Ann Rheum Dis; 2010 Jan; 69(1):113-9. PubMed ID: 19304567
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.
Raynauld JP; Goldsmith CH; Bellamy N; Torrance GW; Polisson R; Belovich D; Pericak D; Tugwell P
Osteoarthritis Cartilage; 2005 Feb; 13(2):111-9. PubMed ID: 15694572
[TBL] [Abstract][Full Text] [Related]
7. Delayed Total Knee Replacement with Hylan G-F 20.
Waddell DD; Joseph B
J Knee Surg; 2016 Feb; 29(2):159-68. PubMed ID: 25349988
[TBL] [Abstract][Full Text] [Related]
8. Total knee replacement delayed with Hylan G-F 20 use in patients with grade IV osteoarthritis.
Waddell DD; Bricker DC
J Manag Care Pharm; 2007 Mar; 13(2):113-121. PubMed ID: 17330972
[TBL] [Abstract][Full Text] [Related]
9. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
Waddell DD; Cefalu CA; Bricker DC
Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial.
Leopold SS; Redd BB; Warme WJ; Wehrle PA; Pettis PD; Shott S
J Bone Joint Surg Am; 2003 Jul; 85(7):1197-203. PubMed ID: 12851342
[TBL] [Abstract][Full Text] [Related]
11. Intra-Articular, Single-Shot Hylan G-F 20 Hyaluronic Acid Injection Compared with Corticosteroid in Knee Osteoarthritis: A Double-Blind, Randomized Controlled Trial.
Tammachote N; Kanitnate S; Yakumpor T; Panichkul P
J Bone Joint Surg Am; 2016 Jun; 98(11):885-92. PubMed ID: 27252432
[TBL] [Abstract][Full Text] [Related]
12. A single intra-articular injection of 2.0% non-chemically modified sodium hyaluronate vs 0.8% hylan G-F 20 in the treatment of symptomatic knee osteoarthritis: A 6-month, multicenter, randomized, controlled non-inferiority trial.
Maheu E; Avouac B; Dreiser RL; Bardin T
PLoS One; 2019; 14(12):e0226007. PubMed ID: 31821355
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline.
Brander V; Skrepnik N; Petrella RJ; Jiang GL; Accomando B; Vardanyan A
Osteoarthritis Cartilage; 2019 Jan; 27(1):59-70. PubMed ID: 30223023
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized trial comparing the efficacy of single 6-ml injection of hylan G-F 20 and hyaluronic acid for primary knee arthritis: a preliminary study.
Khanasuk Y; Dechmaneenin T; Tanavalee A
J Med Assoc Thai; 2012 Oct; 95 Suppl 10():S92-7. PubMed ID: 23451445
[TBL] [Abstract][Full Text] [Related]
15. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee.
Wobig M; Dickhut A; Maier R; Vetter G
Clin Ther; 1998; 20(3):410-23. PubMed ID: 9663358
[TBL] [Abstract][Full Text] [Related]
16. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan.
Wobig M; Bach G; Beks P; Dickhut A; Runzheimer J; Schwieger G; Vetter G; Balazs E
Clin Ther; 1999 Sep; 21(9):1549-62. PubMed ID: 10509850
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Hylan G-F 20 Treatment with Opioid Prescriptions and Intraarticular Corticosteroid Injections in Patients with Osteoarthritis of the Knee Using a Claims Database.
Langworthy MJ; Hummer CD; Ngai W; Hao L; Webner D
Cartilage; 2021 Dec; 13(1_suppl):1586S-1597S. PubMed ID: 33095034
[TBL] [Abstract][Full Text] [Related]
18. Viscosupplementation with hylan G-F 20 (Synvisc): pain and mobility observations from 74 consecutive patients.
Lee S; Park D; Chmell SJ
J Knee Surg; 2004 Apr; 17(2):73-7. PubMed ID: 15124659
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review.
Espallargues M; Pons JM
Int J Technol Assess Health Care; 2003; 19(1):41-56. PubMed ID: 12701938
[TBL] [Abstract][Full Text] [Related]
20. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
Kemper F; Gebhardt U; Meng T; Murray C
Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
